Complementary Use of U.S. FDA’s Adverse Event Reporting...

  • Main
  • 2020 / 10
  • Complementary Use of U.S. FDA’s Adverse Event Reporting...

Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis

Mohamoud, Mohamed, Horgan, Casie, Eworuke, Efe, Dee, Elizabeth, Bohn, Justin, Shapira, Oren, Munoz, Monica A., Stojanovic, Danijela, Sansing‐Foster, Veronica, Ajao, Adebola, La Grenade, Lois
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
DOI:
10.1002/phar.2468
Date:
October, 2020
File:
PDF, 7.92 MB
2020
Conversion to is in progress
Conversion to is failed